nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—ABCC1—Vinblastine—head and neck cancer	0.231	0.338	CbGbCtD
Idarubicin—ABCC1—Docetaxel—head and neck cancer	0.191	0.278	CbGbCtD
Idarubicin—CYP2D6—Hydroxyurea—head and neck cancer	0.149	0.217	CbGbCtD
Idarubicin—CYP2C9—Fluorouracil—head and neck cancer	0.0621	0.0906	CbGbCtD
Idarubicin—CYP2D6—Vinblastine—head and neck cancer	0.0526	0.0767	CbGbCtD
Idarubicin—Radiation injury—Hydroxyurea—head and neck cancer	0.0214	0.0734	CcSEcCtD
Idarubicin—Neutropenic enterocolitis—Docetaxel—head and neck cancer	0.0162	0.0555	CcSEcCtD
Idarubicin—Recall phenomenon—Hydroxyurea—head and neck cancer	0.0129	0.0444	CcSEcCtD
Idarubicin—Palmar-plantar erythrodysaesthesia syndrome—Docetaxel—head and neck cancer	0.0101	0.0347	CcSEcCtD
Idarubicin—Neutropenic colitis—Docetaxel—head and neck cancer	0.0101	0.0347	CcSEcCtD
Idarubicin—Leukaemia—Hydroxyurea—head and neck cancer	0.00834	0.0286	CcSEcCtD
Idarubicin—Radiation recall reaction (dermatologic)—Docetaxel—head and neck cancer	0.00711	0.0244	CcSEcCtD
Idarubicin—Cardiotoxicity—Fluorouracil—head and neck cancer	0.00686	0.0235	CcSEcCtD
Idarubicin—Recall phenomenon—Docetaxel—head and neck cancer	0.00673	0.0231	CcSEcCtD
Idarubicin—Myelodysplastic syndrome—Docetaxel—head and neck cancer	0.00581	0.0199	CcSEcCtD
Idarubicin—Septic shock—Fluorouracil—head and neck cancer	0.00535	0.0183	CcSEcCtD
Idarubicin—Myelosuppression—Vinblastine—head and neck cancer	0.00525	0.018	CcSEcCtD
Idarubicin—Cardiotoxicity—Docetaxel—head and neck cancer	0.00495	0.017	CcSEcCtD
Idarubicin—Myelosuppression—Hydroxyurea—head and neck cancer	0.00479	0.0164	CcSEcCtD
Idarubicin—Enterocolitis—Docetaxel—head and neck cancer	0.0042	0.0144	CcSEcCtD
Idarubicin—Mucosal inflammation—Hydroxyurea—head and neck cancer	0.00406	0.0139	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00378	0.0129	CcSEcCtD
Idarubicin—Pericarditis—Fluorouracil—head and neck cancer	0.00374	0.0128	CcSEcCtD
Idarubicin—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.00373	0.0128	CcSEcCtD
Idarubicin—Myelosuppression—Fluorouracil—head and neck cancer	0.00345	0.0118	CcSEcCtD
Idarubicin—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00333	0.0114	CcSEcCtD
Idarubicin—Cardiomyopathy—Fluorouracil—head and neck cancer	0.00316	0.0108	CcSEcCtD
Idarubicin—Local reaction—Fluorouracil—head and neck cancer	0.00292	0.01	CcSEcCtD
Idarubicin—Sinus tachycardia—Docetaxel—head and neck cancer	0.0029	0.00993	CcSEcCtD
Idarubicin—Extravasation—Vinblastine—head and neck cancer	0.00282	0.00967	CcSEcCtD
Idarubicin—Rash generalised—Docetaxel—head and neck cancer	0.00274	0.00941	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00272	0.00931	CcSEcCtD
Idarubicin—Febrile neutropenia—Fluorouracil—head and neck cancer	0.00269	0.00921	CcSEcCtD
Idarubicin—Myelosuppression—Docetaxel—head and neck cancer	0.00249	0.00853	CcSEcCtD
Idarubicin—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00242	0.0083	CcSEcCtD
Idarubicin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.00242	0.317	CbGdCrCtD
Idarubicin—Ulcer—Hydroxyurea—head and neck cancer	0.00237	0.00814	CcSEcCtD
Idarubicin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.00237	0.311	CbGdCrCtD
Idarubicin—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00229	0.00784	CcSEcCtD
Idarubicin—Neoplasm—Vinblastine—head and neck cancer	0.00223	0.00763	CcSEcCtD
Idarubicin—Mucosal inflammation—Docetaxel—head and neck cancer	0.00211	0.00722	CcSEcCtD
Idarubicin—Phlebitis—Vinblastine—head and neck cancer	0.00207	0.00711	CcSEcCtD
Idarubicin—Necrosis—Fluorouracil—head and neck cancer	0.00206	0.00706	CcSEcCtD
Idarubicin—Neoplasm—Hydroxyurea—head and neck cancer	0.00203	0.00696	CcSEcCtD
Idarubicin—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00196	0.00672	CcSEcCtD
Idarubicin—Febrile neutropenia—Docetaxel—head and neck cancer	0.00194	0.00665	CcSEcCtD
Idarubicin—Extravasation—Fluorouracil—head and neck cancer	0.00185	0.00635	CcSEcCtD
Idarubicin—Embolism—Docetaxel—head and neck cancer	0.00182	0.00623	CcSEcCtD
Idarubicin—Ulcer—Fluorouracil—head and neck cancer	0.00171	0.00586	CcSEcCtD
Idarubicin—Burning sensation—Docetaxel—head and neck cancer	0.00168	0.00576	CcSEcCtD
Idarubicin—Daunorubicin—CYP1A1—head and neck cancer	0.00156	1	CrCbGaD
Idarubicin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.00153	0.2	CbGdCrCtD
Idarubicin—Necrosis—Docetaxel—head and neck cancer	0.00149	0.00509	CcSEcCtD
Idarubicin—Oesophagitis—Fluorouracil—head and neck cancer	0.00148	0.00506	CcSEcCtD
Idarubicin—Pancytopenia—Vinblastine—head and neck cancer	0.00147	0.00503	CcSEcCtD
Idarubicin—Sepsis—Fluorouracil—head and neck cancer	0.0014	0.00481	CcSEcCtD
Idarubicin—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00136	0.00465	CcSEcCtD
Idarubicin—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00136	0.00465	CcSEcCtD
Idarubicin—Myocardial infarction—Vinblastine—head and neck cancer	0.00135	0.00463	CcSEcCtD
Idarubicin—Pancytopenia—Hydroxyurea—head and neck cancer	0.00134	0.00459	CcSEcCtD
Idarubicin—Extravasation—Docetaxel—head and neck cancer	0.00134	0.00458	CcSEcCtD
Idarubicin—Neutropenia—Hydroxyurea—head and neck cancer	0.00132	0.00452	CcSEcCtD
Idarubicin—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.0013	0.171	CbGdCrCtD
Idarubicin—TOP2A—G0 and Early G1—CCNA1—head and neck cancer	0.00127	0.0954	CbGpPWpGaD
Idarubicin—Haemoglobin—Vinblastine—head and neck cancer	0.00124	0.00426	CcSEcCtD
Idarubicin—Haemorrhage—Vinblastine—head and neck cancer	0.00124	0.00424	CcSEcCtD
Idarubicin—Stomatitis—Hydroxyurea—head and neck cancer	0.00122	0.0042	CcSEcCtD
Idarubicin—Haemoglobin—Hydroxyurea—head and neck cancer	0.00113	0.00388	CcSEcCtD
Idarubicin—TOP2A—Gastric Cancer Network 1—CCNA1—head and neck cancer	0.00113	0.0847	CbGpPWpGaD
Idarubicin—Haemorrhage—Hydroxyurea—head and neck cancer	0.00113	0.00387	CcSEcCtD
Idarubicin—Colitis—Docetaxel—head and neck cancer	0.00112	0.00384	CcSEcCtD
Idarubicin—Alopecia—Vinblastine—head and neck cancer	0.00109	0.00375	CcSEcCtD
Idarubicin—Oesophagitis—Docetaxel—head and neck cancer	0.00107	0.00365	CcSEcCtD
Idarubicin—Neoplasm—Docetaxel—head and neck cancer	0.00105	0.00362	CcSEcCtD
Idarubicin—Angiopathy—Hydroxyurea—head and neck cancer	0.00102	0.00351	CcSEcCtD
Idarubicin—Sepsis—Docetaxel—head and neck cancer	0.00101	0.00347	CcSEcCtD
Idarubicin—Chills—Hydroxyurea—head and neck cancer	0.00101	0.00347	CcSEcCtD
Idarubicin—Alopecia—Hydroxyurea—head and neck cancer	0.000997	0.00342	CcSEcCtD
Idarubicin—Anaemia—Vinblastine—head and neck cancer	0.000995	0.00341	CcSEcCtD
Idarubicin—Phlebitis—Docetaxel—head and neck cancer	0.000983	0.00337	CcSEcCtD
Idarubicin—Thrombophlebitis—Docetaxel—head and neck cancer	0.000978	0.00335	CcSEcCtD
Idarubicin—Leukopenia—Vinblastine—head and neck cancer	0.000964	0.0033	CcSEcCtD
Idarubicin—Pancytopenia—Fluorouracil—head and neck cancer	0.000963	0.0033	CcSEcCtD
Idarubicin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000934	0.0032	CcSEcCtD
Idarubicin—Convulsion—Vinblastine—head and neck cancer	0.000933	0.0032	CcSEcCtD
Idarubicin—Anaemia—Hydroxyurea—head and neck cancer	0.000907	0.00311	CcSEcCtD
Idarubicin—Hot flush—Docetaxel—head and neck cancer	0.000905	0.0031	CcSEcCtD
Idarubicin—Menopausal symptoms—Docetaxel—head and neck cancer	0.000898	0.00308	CcSEcCtD
Idarubicin—Atrial fibrillation—Docetaxel—head and neck cancer	0.000894	0.00306	CcSEcCtD
Idarubicin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000891	0.00306	CcSEcCtD
Idarubicin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000886	0.00304	CcSEcCtD
Idarubicin—Stomatitis—Fluorouracil—head and neck cancer	0.000881	0.00302	CcSEcCtD
Idarubicin—Leukopenia—Hydroxyurea—head and neck cancer	0.000879	0.00301	CcSEcCtD
Idarubicin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00086	0.00295	CcSEcCtD
Idarubicin—Convulsion—Hydroxyurea—head and neck cancer	0.000851	0.00292	CcSEcCtD
Idarubicin—Anorexia—Vinblastine—head and neck cancer	0.000837	0.00287	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00083	0.00284	CcSEcCtD
Idarubicin—Haemoglobin—Fluorouracil—head and neck cancer	0.000816	0.0028	CcSEcCtD
Idarubicin—Haemorrhage—Fluorouracil—head and neck cancer	0.000812	0.00278	CcSEcCtD
Idarubicin—Infection—Hydroxyurea—head and neck cancer	0.000796	0.00273	CcSEcCtD
Idarubicin—Dehydration—Docetaxel—head and neck cancer	0.000788	0.0027	CcSEcCtD
Idarubicin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000784	0.00269	CcSEcCtD
Idarubicin—Skin disorder—Hydroxyurea—head and neck cancer	0.000778	0.00267	CcSEcCtD
Idarubicin—Anorexia—Hydroxyurea—head and neck cancer	0.000764	0.00262	CcSEcCtD
Idarubicin—Decreased appetite—Vinblastine—head and neck cancer	0.000764	0.00262	CcSEcCtD
Idarubicin—Arrhythmia—Fluorouracil—head and neck cancer	0.000725	0.00249	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000718	0.00246	CcSEcCtD
Idarubicin—Alopecia—Fluorouracil—head and neck cancer	0.000717	0.00246	CcSEcCtD
Idarubicin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000696	0.00239	CcSEcCtD
Idarubicin—Pancytopenia—Docetaxel—head and neck cancer	0.000695	0.00238	CcSEcCtD
Idarubicin—Abdominal pain—Vinblastine—head and neck cancer	0.000695	0.00238	CcSEcCtD
Idarubicin—Neutropenia—Docetaxel—head and neck cancer	0.000684	0.00235	CcSEcCtD
Idarubicin—Anaemia—Fluorouracil—head and neck cancer	0.000653	0.00224	CcSEcCtD
Idarubicin—Hypersensitivity—Vinblastine—head and neck cancer	0.000647	0.00222	CcSEcCtD
Idarubicin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000643	0.00221	CcSEcCtD
Idarubicin—Myocardial infarction—Docetaxel—head and neck cancer	0.00064	0.00219	CcSEcCtD
Idarubicin—Stomatitis—Docetaxel—head and neck cancer	0.000636	0.00218	CcSEcCtD
Idarubicin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000633	0.00217	CcSEcCtD
Idarubicin—Leukopenia—Fluorouracil—head and neck cancer	0.000633	0.00217	CcSEcCtD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.000617	0.0463	CbGpPWpGaD
Idarubicin—Convulsion—Fluorouracil—head and neck cancer	0.000612	0.0021	CcSEcCtD
Idarubicin—Chest pain—Fluorouracil—head and neck cancer	0.000602	0.00206	CcSEcCtD
Idarubicin—Diarrhoea—Vinblastine—head and neck cancer	0.000601	0.00206	CcSEcCtD
Idarubicin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00059	0.00202	CcSEcCtD
Idarubicin—Haemoglobin—Docetaxel—head and neck cancer	0.000589	0.00202	CcSEcCtD
Idarubicin—Haemorrhage—Docetaxel—head and neck cancer	0.000586	0.00201	CcSEcCtD
Idarubicin—Urinary tract disorder—Docetaxel—head and neck cancer	0.000579	0.00198	CcSEcCtD
Idarubicin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000577	0.00198	CcSEcCtD
Idarubicin—Urethral disorder—Docetaxel—head and neck cancer	0.000574	0.00197	CcSEcCtD
Idarubicin—Infection—Fluorouracil—head and neck cancer	0.000573	0.00196	CcSEcCtD
Idarubicin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000565	0.00194	CcSEcCtD
Idarubicin—Vomiting—Vinblastine—head and neck cancer	0.000559	0.00191	CcSEcCtD
Idarubicin—Headache—Vinblastine—head and neck cancer	0.00055	0.00189	CcSEcCtD
Idarubicin—Anorexia—Fluorouracil—head and neck cancer	0.00055	0.00188	CcSEcCtD
Idarubicin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000548	0.00188	CcSEcCtD
Idarubicin—Flushing—Docetaxel—head and neck cancer	0.000544	0.00186	CcSEcCtD
Idarubicin—Angiopathy—Docetaxel—head and neck cancer	0.000532	0.00182	CcSEcCtD
Idarubicin—Immune system disorder—Docetaxel—head and neck cancer	0.000529	0.00181	CcSEcCtD
Idarubicin—Chills—Docetaxel—head and neck cancer	0.000526	0.0018	CcSEcCtD
Idarubicin—Arrhythmia—Docetaxel—head and neck cancer	0.000523	0.00179	CcSEcCtD
Idarubicin—Nausea—Vinblastine—head and neck cancer	0.000522	0.00179	CcSEcCtD
Idarubicin—Alopecia—Docetaxel—head and neck cancer	0.000518	0.00177	CcSEcCtD
Idarubicin—Malnutrition—Docetaxel—head and neck cancer	0.00051	0.00175	CcSEcCtD
Idarubicin—Vomiting—Hydroxyurea—head and neck cancer	0.000509	0.00175	CcSEcCtD
Idarubicin—Rash—Hydroxyurea—head and neck cancer	0.000505	0.00173	CcSEcCtD
Idarubicin—Dermatitis—Hydroxyurea—head and neck cancer	0.000505	0.00173	CcSEcCtD
Idarubicin—Headache—Hydroxyurea—head and neck cancer	0.000502	0.00172	CcSEcCtD
Idarubicin—Decreased appetite—Fluorouracil—head and neck cancer	0.000501	0.00172	CcSEcCtD
Idarubicin—Nausea—Hydroxyurea—head and neck cancer	0.000476	0.00163	CcSEcCtD
Idarubicin—Anaemia—Docetaxel—head and neck cancer	0.000471	0.00162	CcSEcCtD
Idarubicin—Urticaria—Fluorouracil—head and neck cancer	0.000458	0.00157	CcSEcCtD
Idarubicin—Leukopenia—Docetaxel—head and neck cancer	0.000457	0.00156	CcSEcCtD
Idarubicin—Body temperature increased—Fluorouracil—head and neck cancer	0.000456	0.00156	CcSEcCtD
Idarubicin—Convulsion—Docetaxel—head and neck cancer	0.000442	0.00151	CcSEcCtD
Idarubicin—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00044	0.033	CbGpPWpGaD
Idarubicin—Chest pain—Docetaxel—head and neck cancer	0.000434	0.00149	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000431	0.00148	CcSEcCtD
Idarubicin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000425	0.00146	CcSEcCtD
Idarubicin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000416	0.00143	CcSEcCtD
Idarubicin—Infection—Docetaxel—head and neck cancer	0.000414	0.00142	CcSEcCtD
Idarubicin—Shock—Docetaxel—head and neck cancer	0.00041	0.0014	CcSEcCtD
Idarubicin—TOP2A—Gastric Cancer Network 1—NOTCH1—head and neck cancer	0.000409	0.0307	CbGpPWpGaD
Idarubicin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000408	0.0014	CcSEcCtD
Idarubicin—Skin disorder—Docetaxel—head and neck cancer	0.000404	0.00139	CcSEcCtD
Idarubicin—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000401	0.0301	CbGpPWpGaD
Idarubicin—Anorexia—Docetaxel—head and neck cancer	0.000397	0.00136	CcSEcCtD
Idarubicin—Diarrhoea—Fluorouracil—head and neck cancer	0.000395	0.00135	CcSEcCtD
Idarubicin—Vomiting—Fluorouracil—head and neck cancer	0.000367	0.00126	CcSEcCtD
Idarubicin—Rash—Fluorouracil—head and neck cancer	0.000364	0.00125	CcSEcCtD
Idarubicin—Dermatitis—Fluorouracil—head and neck cancer	0.000363	0.00125	CcSEcCtD
Idarubicin—Decreased appetite—Docetaxel—head and neck cancer	0.000362	0.00124	CcSEcCtD
Idarubicin—Headache—Fluorouracil—head and neck cancer	0.000361	0.00124	CcSEcCtD
Idarubicin—Nausea—Fluorouracil—head and neck cancer	0.000343	0.00117	CcSEcCtD
Idarubicin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00034	0.00117	CcSEcCtD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.00033	0.0248	CbGpPWpGaD
Idarubicin—Abdominal pain—Docetaxel—head and neck cancer	0.000329	0.00113	CcSEcCtD
Idarubicin—Body temperature increased—Docetaxel—head and neck cancer	0.000329	0.00113	CcSEcCtD
Idarubicin—Hypersensitivity—Docetaxel—head and neck cancer	0.000307	0.00105	CcSEcCtD
Idarubicin—ABCC1—S1P1 pathway—PTGS2—head and neck cancer	0.000295	0.0221	CbGpPWpGaD
Idarubicin—Diarrhoea—Docetaxel—head and neck cancer	0.000285	0.000976	CcSEcCtD
Idarubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.000278	0.0209	CbGpPWpGaD
Idarubicin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00027	0.0203	CbGpPWpGaD
Idarubicin—Vomiting—Docetaxel—head and neck cancer	0.000265	0.000907	CcSEcCtD
Idarubicin—Rash—Docetaxel—head and neck cancer	0.000262	0.0009	CcSEcCtD
Idarubicin—Dermatitis—Docetaxel—head and neck cancer	0.000262	0.000899	CcSEcCtD
Idarubicin—Headache—Docetaxel—head and neck cancer	0.000261	0.000894	CcSEcCtD
Idarubicin—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000255	0.0191	CbGpPWpGaD
Idarubicin—Nausea—Docetaxel—head and neck cancer	0.000247	0.000847	CcSEcCtD
Idarubicin—ABCC1—S1P1 pathway—VEGFA—head and neck cancer	0.000232	0.0174	CbGpPWpGaD
Idarubicin—ABCC1—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000231	0.0173	CbGpPWpGaD
Idarubicin—ABCC1—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000229	0.0172	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000226	0.017	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000221	0.0166	CbGpPWpGaD
Idarubicin—ABCC1—S1P1 pathway—MAPK3—head and neck cancer	0.00022	0.0165	CbGpPWpGaD
Idarubicin—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000213	0.016	CbGpPWpGaD
Idarubicin—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000212	0.0159	CbGpPWpGaD
Idarubicin—ABCC1—S1P1 pathway—MAPK1—head and neck cancer	0.000209	0.0157	CbGpPWpGaD
Idarubicin—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000205	0.0154	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—EGFR—head and neck cancer	0.000204	0.0153	CbGpPWpGaD
Idarubicin—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000204	0.0153	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000201	0.0151	CbGpPWpGaD
Idarubicin—TOP2A—Gastric Cancer Network 2—TP53—head and neck cancer	0.000171	0.0129	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000159	0.0119	CbGpPWpGaD
Idarubicin—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000159	0.0119	CbGpPWpGaD
Idarubicin—ABCC1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000136	0.0102	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000121	0.00908	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000121	0.00905	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TYMS—head and neck cancer	0.000116	0.00869	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000114	0.00855	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCNA1—head and neck cancer	0.000108	0.00812	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000103	0.0077	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000102	0.00762	CbGpPWpGaD
Idarubicin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.86e-05	0.00665	CbGpPWpGaD
Idarubicin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.79e-05	0.00659	CbGpPWpGaD
Idarubicin—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.75e-05	0.00656	CbGpPWpGaD
Idarubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	8.73e-05	0.00655	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—RAD51—head and neck cancer	8.7e-05	0.00653	CbGpPWpGaD
Idarubicin—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.67e-05	0.0065	CbGpPWpGaD
Idarubicin—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	8.4e-05	0.0063	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.25e-05	0.00619	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—NAT2—head and neck cancer	8.15e-05	0.00611	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—NAT2—head and neck cancer	8.08e-05	0.00606	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	8.04e-05	0.00603	CbGpPWpGaD
Idarubicin—TOP2A—Mitotic G1-G1/S phases—CCND1—head and neck cancer	8.02e-05	0.00602	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	7.97e-05	0.00598	CbGpPWpGaD
Idarubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	7.51e-05	0.00563	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—UROD—head and neck cancer	7.49e-05	0.00562	CbGpPWpGaD
Idarubicin—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.19e-05	0.00539	CbGpPWpGaD
Idarubicin—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.12e-05	0.00534	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.08e-05	0.00531	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	6.73e-05	0.00504	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.08e-05	0.00456	CbGpPWpGaD
Idarubicin—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.05e-05	0.00453	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	5.87e-05	0.0044	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	5.84e-05	0.00438	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.81e-05	0.00436	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	5.63e-05	0.00422	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.3e-05	0.00397	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TYMS—head and neck cancer	5.23e-05	0.00392	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.01e-05	0.00376	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	4.77e-05	0.00358	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	4.77e-05	0.00358	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.14e-05	0.0031	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	4.03e-05	0.00302	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4e-05	0.003	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	3.99e-05	0.00299	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	3.97e-05	0.00298	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	3.94e-05	0.00295	CbGpPWpGaD
Idarubicin—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	3.84e-05	0.00288	CbGpPWpGaD
Idarubicin—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	3.82e-05	0.00286	CbGpPWpGaD
Idarubicin—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	3.78e-05	0.00284	CbGpPWpGaD
Idarubicin—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	3.76e-05	0.00282	CbGpPWpGaD
Idarubicin—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	3.73e-05	0.0028	CbGpPWpGaD
Idarubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.38e-05	0.00254	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—UROD—head and neck cancer	3.36e-05	0.00252	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—UROD—head and neck cancer	3.33e-05	0.0025	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.3e-05	0.00248	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.27e-05	0.00245	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—NAT2—head and neck cancer	3.11e-05	0.00233	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	2.94e-05	0.00221	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—DPYD—head and neck cancer	2.73e-05	0.00204	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—CCND1—head and neck cancer	2.63e-05	0.00197	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—YAP1—head and neck cancer	2.59e-05	0.00194	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.58e-05	0.00194	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	2.43e-05	0.00182	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.31e-05	0.00173	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	2.17e-05	0.00163	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	2.06e-05	0.00155	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.94e-05	0.00146	CbGpPWpGaD
Idarubicin—TOP2A—Cell Cycle—TP53—head and neck cancer	1.73e-05	0.0013	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.7e-05	0.00127	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—TYMS—head and neck cancer	1.55e-05	0.00117	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GSTM1—head and neck cancer	1.54e-05	0.00115	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—GPX1—head and neck cancer	1.47e-05	0.0011	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.47e-05	0.0011	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.46e-05	0.00109	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.45e-05	0.00109	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—NAT2—head and neck cancer	1.39e-05	0.00105	CbGpPWpGaD
Idarubicin—ABCC1—Disease—NOTCH1—head and neck cancer	1.39e-05	0.00104	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—NAT2—head and neck cancer	1.38e-05	0.00104	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—DPYD—head and neck cancer	1.22e-05	0.000917	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—DPYD—head and neck cancer	1.21e-05	0.000909	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.2e-05	0.000897	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—YAP1—head and neck cancer	1.16e-05	0.00087	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—YAP1—head and neck cancer	1.15e-05	0.000862	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTGS2—head and neck cancer	1.03e-05	0.000775	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PTEN—head and neck cancer	9.02e-06	0.000676	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTGS2—head and neck cancer	8.66e-06	0.000649	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.64e-06	0.000648	CbGpPWpGaD
Idarubicin—ABCC1—Disease—STAT3—head and neck cancer	8.06e-06	0.000605	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK3—head and neck cancer	7.7e-06	0.000578	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PTEN—head and neck cancer	7.55e-06	0.000566	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.54e-06	0.000565	CbGpPWpGaD
Idarubicin—ABCC1—Disease—MAPK1—head and neck cancer	7.33e-06	0.00055	CbGpPWpGaD
Idarubicin—ABCC1—Disease—EGFR—head and neck cancer	7.33e-06	0.00055	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—TYMS—head and neck cancer	6.97e-06	0.000522	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—TYMS—head and neck cancer	6.91e-06	0.000518	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GSTM1—head and neck cancer	6.89e-06	0.000516	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GSTM1—head and neck cancer	6.83e-06	0.000512	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—GPX1—head and neck cancer	6.59e-06	0.000494	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—GPX1—head and neck cancer	6.54e-06	0.00049	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—CYP1A1—head and neck cancer	6.53e-06	0.000489	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	6.47e-06	0.000485	CbGpPWpGaD
Idarubicin—ABCC1—Disease—PIK3CA—head and neck cancer	6.36e-06	0.000477	CbGpPWpGaD
Idarubicin—ABCC1—Disease—HRAS—head and neck cancer	5.89e-06	0.000441	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—PIK3CA—head and neck cancer	5.33e-06	0.000399	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.32e-06	0.000399	CbGpPWpGaD
Idarubicin—ABCC1—Disease—AKT1—head and neck cancer	5.2e-06	0.00039	CbGpPWpGaD
Idarubicin—ABCC1—Metabolism—AKT1—head and neck cancer	4.35e-06	0.000326	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.88e-06	0.000291	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.85e-06	0.000289	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PTEN—head and neck cancer	3.39e-06	0.000254	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PTEN—head and neck cancer	3.36e-06	0.000252	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.39e-06	0.000179	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.37e-06	0.000178	CbGpPWpGaD
Idarubicin—CYP2D6—Metabolism—AKT1—head and neck cancer	1.95e-06	0.000146	CbGpPWpGaD
Idarubicin—CYP2C9—Metabolism—AKT1—head and neck cancer	1.93e-06	0.000145	CbGpPWpGaD
